Craig S. Atwood, PhD, University of Western Australia,1993 - Related publications

Medicine University of Wisconsin, Madison, Madison, WI 
Alzheimer disease and Aging
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
23 most relevant papers in past 60 days:
Year Citation  Score
2022 Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, Blennow K, Cummings J, van Duijn C, Nilsson PM, Dietrich PY, Scheltens P, Dubois B. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nature Reviews. Neuroscience. 23: 53-66. PMID 34815562 DOI: 10.1038/s41583-021-00533-w   
2022 Thuraisingham RA. A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer's disease. Metabolic Brain Disease. PMID 35032278 DOI: 10.1007/s11011-022-00902-z   
2022 Zamanian J, Khoshbin Z, Abnous K, Taghdisi SM, Hosseinzadeh H, Danesh NM. Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers. Biosensors & Bioelectronics. 197: 113789. PMID 34798498 DOI: 10.1016/j.bios.2021.113789   
2022 Pons V, Rivest S. Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease. Pharmacological Reviews. 74: 1-17. PMID 34987086 DOI: 10.1124/pharmrev.121.000400   
2022 Asih PR, Stefanoska K, Prikas E, Ittner A. High level forebrain expression of active tau kinase p38γ exacerbates cognitive dysfunction in aged APP-transgenic alzheimer's mice. Neuroscience. PMID 35031398 DOI: 10.1016/j.neuroscience.2022.01.005   
2022 Tang JJ, Huang LF, Deng JL, Wang YM, Guo C, Peng XN, Liu Z, Gao JM. Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model. Redox Biology. 50: 102229. PMID 35026701 DOI: 10.1016/j.redox.2022.102229   
2022 Lee PJ, Tsai CL, Liang CS, Peng GS, Lee JT, Tsai CK, Lin YK, Yang FY. Biomarkers with Plasma Amyloid β and Tau Protein Assayed by Immunomagnetic Reduction in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Acta Neurologica Taiwanica. 31: 53-60. PMID 35040113   
2022 Lee D, Park JC, Jung KS, Kim J, Jang JS, Kwon S, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. Application of QPLEX biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition. Experimental & Molecular Medicine. PMID 35058557 DOI: 10.1038/s12276-021-00719-3   
2022 Sharma L, Sharma A, Kumar D, Asthana MK, Lalhlenmawia H, Kumar A, Bhattacharyya S, Kumar D. Promising protein biomarkers in the early diagnosis of Alzheimer's disease. Metabolic Brain Disease. PMID 35015199 DOI: 10.1007/s11011-021-00847-9   
2022 Lin L, Hua F, Salinas C, Young C, Bussiere T, Apgar JF, Burke JM, Muralidharan K, Rajagovindan R, Nestorov I. Quantitative systems pharmacology model for Alzheimer's disease to predict effect of aducanumab on brain amyloid. Cpt: Pharmacometrics & Systems Pharmacology. PMID 35029320 DOI: 10.1002/psp4.12759   
2022 Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, Anderson ET, Ivanova E, Lin H, Sagdullaev BT, Chen J, Klein WL, Viola KL, Gandy S, Haroutunian V, et al. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease. Nature Communications. 13: 159. PMID 35013160 DOI: 10.1038/s41467-021-27572-2   
2022 Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet. Neurology. 21: 66-77. PMID 34838239 DOI: 10.1016/S1474-4422(21)00361-6   
2022 Islam S, Sun Y, Gao Y, Nakamura T, Noorani AA, Li T, Wong PC, Kimura N, Matsubara E, Kasuga K, Ikeuchi T, Tomita T, Zou K, Michikawa M. Presenilin is essential for ApoE secretion, a novel role of presenilin involved in Alzheimer's disease pathogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34987110 DOI: 10.1523/JNEUROSCI.2039-21.2021   
2022 Bigley TM, Xiong M, Ali M, Chen Y, Wang C, Serrano JR, Eteleeb A, Harari O, Yang L, Patel SJ, Cruchaga C, Yokoyama WM, Holtzman DM. Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains. Molecular Neurodegeneration. 17: 10. PMID 35033173 DOI: 10.1186/s13024-021-00514-8   
2022 Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... , et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6   
2022 Jia J, Zhang X, Xu G, Zeng X, Li L. Thioredoxin-1 inhibits amyloid-β-induced activation of NLRP1/caspase-1/GSDMD pyroptotic pathway in PC12 cells. Molecular Biology Reports. PMID 35072836 DOI: 10.1007/s11033-022-07177-8   
2022 Ferreira CB, Marttinen M, Coelho JE, Paldanius KMA, Takalo M, Mäkinen P, Leppänen L, Miranda-Lourenço C, Fonseca-Gomes J, Tanqueiro SR, Vaz SH, Belo RF, Sebastião AM, Leinonen V, Soininen H, et al. S327 phosphorylation of the presynaptic protein SEPTIN5 increases in the early stages of neurofibrillary pathology and alters the functionality of SEPTIN5. Neurobiology of Disease. 163: 105603. PMID 34954322 DOI: 10.1016/j.nbd.2021.105603   
2022 Fan D, Li H, Chen D, Chen Y, Yi X, Yang H, Shi Q, Jiao F, Tang Y, Li Q, Wang F, Wang S, Jin R, Zeng F, Wang Y. Chronic hypoperfusion due to intracranial large artery stenosis is not associated with cerebral β-amyloid deposition and brain atrophy. Chinese Medical Journal. PMID 34985014 DOI: 10.1097/CM9.0000000000001918   
2022 Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease. Jama Neurology. 79: 13-21. PMID 34807243 DOI: 10.1001/jamaneurol.2021.4161   
2022 Reyes-Dumeyer D, Faber K, Vardarajan B, Goate A, Renton A, Chao M, Boeve B, Cruchaga C, Pericak-Vance M, Haines JL, Rosenberg R, Tsuang D, Sweet RA, Bennett DA, Wilson RS, et al. The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34978149 DOI: 10.1002/alz.12514   
2022 Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer's Disease. Stem Cell Reviews and Reports. PMID 34997526 DOI: 10.1007/s12015-021-10321-9   
2022 Geng D, Wang Y, Gao Z, Wang J, Liu X, Pang G. Effects of Alzheimer's disease of varying severity on cardiac and autonomic function. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 55: e11504. PMID 35019033 DOI: 10.1590/1414-431X2021e11504   
2022 Fagan SG, Bechet S, Dev KK. Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease. Molecular Neurobiology. PMID 35031916 DOI: 10.1007/s12035-021-02613-5